Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02854917 · ClinicalTrials.gov registry record
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 20
- Enrollment target
NCT02854917 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 20 participants.
The verdict
NCT02854917 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study is a retrospective review of the data collected in a previously completed randomized, controlled trial (RCT) entitled "Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial" (NCT00120874). As part of the previously completed RCT, participants with Alzheimer's Disease (AD) were randomly placed into one of two groups: memantine, or memantine plus an individualized management program consisting of home visits, educational sessions for caregivers, and a caregiver support group. Participants received the study intervention for 28 weeks; study follow-up lasted for 52 weeks. The collected data from the existing study books from the 28 week treatment portion of the RCT will be carefully examined with respect to each of the research questions for the present retrospective study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-01-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02854917
The ClinicalTrials.gov registry entry for NCT02854917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02854917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02854917 about?
NCT02854917 is a clinical study titled "Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome". This study is a retrospective review of the data collected in a previously completed randomized, controlled trial (RCT) entitled "Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial" (NCT00120874). As part of the previously c...
What is the current status of trial NCT02854917?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2016-07. Estimated completion is 2018-01-05.
Who is sponsoring clinical trial NCT02854917?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.